It's been less than a year since Jonathan Silverstein, a venture capitalist at health-care fund OrbiMed, received the diagnosis that changed everything.Parkinson's disease at age 49. A potentially more aggressive, inherited form, driven by a mutation in a gene called GBA. It affects up to 10 percent of Americans with Parkinson's, and — as for other...